http://venturebeat.com/2007/08/02/juvaris-bio-wins-9m-grant-for-flu-vaccine-adjuvants/ News About Tech, Money and Innovation Tue, 24 Nov 2009 06:27:18 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/08/02/juvaris-bio-wins-9m-grant-for-flu-vaccine-adjuvants/comment-page-1/#comment-664288 VentureBeat » Life sciences briefing: Friday, Nov. 2, 2007 Wed, 05 Dec 2007 01:20:01 +0000 http://venturebeat.com/2007/08/02/juvaris-bio-wins-9m-grant-for-flu-vaccine-adjuvants/#comment-664288 [...] Juvaris is developing vaccines against infectious disease and cancer using adjuvants — substances that enhance immune response, and thus the activity of vaccines — made from complexes formed by out of complexes of DNA and fatty molecules called lipids. We previously covered the company here. [...] [...] Juvaris is developing vaccines against infectious disease and cancer using adjuvants — substances that enhance immune response, and thus the activity of vaccines — made from complexes formed by out of complexes of DNA and fatty molecules called lipids. We previously covered the company here. [...]

]]> http://venturebeat.com/2007/08/02/juvaris-bio-wins-9m-grant-for-flu-vaccine-adjuvants/comment-page-1/#comment-643498 VentureBeat » Life sciences briefing: Tuesday, Nov. 20, 2007 Tue, 20 Nov 2007 21:55:07 +0000 http://venturebeat.com/2007/08/02/juvaris-bio-wins-9m-grant-for-flu-vaccine-adjuvants/#comment-643498 [...] Kleiner Perkins Caufield & Byers provided the funding. Juvaris is developing vaccines against cancer and infectious disease using “adjuvants” — composed of DNA complexes and fatty molecules known as lipids — that stimulate immune responses. For additional coverage of the company, see here. [...] [...] Kleiner Perkins Caufield & Byers provided the funding. Juvaris is developing vaccines against cancer and infectious disease using “adjuvants” — composed of DNA complexes and fatty molecules known as lipids — that stimulate immune responses. For additional coverage of the company, see here. [...]

]]>